| Sheila Mae Collins, PD | |
|
101 N Main St, Malvern, AR 72104-3501 | |
| (501) 332-2101 | |
| (501) 337-9532 |
| Full Name | Sheila Mae Collins |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 N Main St, Malvern, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700194131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD07299 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Mae Collins, PD 101 N Main St, Malvern, AR 72104-3501 Ph: (501) 332-2101 | Sheila Mae Collins, PD 101 N Main St, Malvern, AR 72104-3501 Ph: (501) 332-2101 |
News Archive
Body Mass Index (BMI), the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
Researchers at Aalto University have developed a simple method for reducing the amount of phosphorus in the wastewater of a pulp mill. The method is called simultaneous precipitation using iron sulphate. A separate treatment stage is not required, as the precipitation takes place simultaneously with the actual biological wastewater treatment.
New research from Edith Cowan University has shown a link between young children's early eating habits and higher levels of traits associated with autism as adults.
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two problems. First, it can't reach its target because it's blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
› Verified 3 days ago
Shalonda Macon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 S Main St, Malvern, AR 72104 Phone: 501-467-8197 | |
Dr. Amber Elizabeth Prescott, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 S Main St, Malvern, AR 72104 Phone: 501-467-8192 Fax: 501-467-8662 | |
Deborah Cooper Brumley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Schneider Dr, Malvern, AR 72104 Phone: 501-332-7356 | |
Justin Clark Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 224 Harmony Acres Rd, Malvern, AR 72104 Phone: 501-337-6015 | |
Samantha Pennington, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1402 Mlk Blvd, Malvern, AR 72104 Phone: 501-229-1446 | |
Jamelyn Landes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 S Main St, Malvern, AR 72104 Phone: 501-467-8197 | |
Dr. Joshua Daniel Robinson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 509 Reyburn Creek Rd, Malvern, AR 72104 Phone: 479-595-4977 |